mTOR pp 421-433 | Cite as

A Mouse Model of Diet-Induced Obesity and Insulin Resistance

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 821)

Abstract

Obesity is reaching pandemic proportions in Western society. It has resulted in increasing health care burden and decreasing life expectancy. Obesity is a complex, chronic disease, involving decades of pathophysiological changes and adaptation. Therefore, it is difficult ascertain the exact mechanisms for this long-term process in humans. To circumvent some of these issues, several surrogate models are available, including murine genetic loss-of-function mutations, transgenic gain-of-function mutations, polygenic models, and different environmental exposure models. The mouse model of diet-induced obesity has become one of the most important tools for understanding the interplay of high-fat Western diets and the development of obesity. The diet-induced obesity model closely mimics the increasingly availability of the high-fat/high-density foods in modern society over the past two decades, which are main contributors to the obesity trend in human. This model has lead to many discoveries of the important signalings in obesity, such as Akt and mTOR. The chapter describes protocols for diet induced-obesity model in mice and protocols for measuring insulin resistance and sensitivity.

Key words

Obesity High-fat diet Insulin resistance Body weight Metabolism 

Notes

Acknowledgments

The author would like to thank Professor Ming-Shien Wen for his advice and encouragement. This work was supported by grants from National Institutes of Health (HL052233, DK085006, NS070001), National Health Research Institutes (NHRI-EX99-9925SC) and National Science Council (98-2314-B-182A-082-MY3).

References

  1. 1.
    Flier, J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337–350 (2004).PubMedCrossRefGoogle Scholar
  2. 2.
    Wisse, B.E., Kim, F. & Schwartz, M.W. Physiology. An integrative view of obesity. Science (New York, N.Y) 318, 928–929 (2007).Google Scholar
  3. 3.
    Sclafani, A. Animal models of obesity: classification and characterization. Int J Obes 8, 491–508 (1984).PubMedGoogle Scholar
  4. 4.
    Zhang, D., et al. Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency. Cell Metab 11, 402–411 (2010).PubMedCrossRefGoogle Scholar
  5. 5.
    Johnson, P.R., Greenwood, M.R., Horwitz, B.A. & Stern, J.S. Animal models of obesity: genetic aspects. Annu Rev Nutr 11, 325–353 (1991).PubMedCrossRefGoogle Scholar
  6. 6.
    Rossmeisl, M., Rim, J.S., Koza, R.A. & Kozak, L.P. Variation in type 2 diabetes – related traits in mouse strains susceptible to diet-induced obesity. Diabetes 52, 1958–1966 (2003).PubMedCrossRefGoogle Scholar
  7. 7.
    York, D.A. Lessons from animal models of obesity. Endocrinol Metab Clin North Am 25, 781–800 (1996).PubMedCrossRefGoogle Scholar
  8. 8.
    Collins, S., Martin, T.L., Surwit, R.S. & Robidoux, J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81, 243–248 (2004).PubMedCrossRefGoogle Scholar
  9. 9.
    Speakman, J., Hambly, C., Mitchell, S. & Krol, E. Animal models of obesity. Obes Rev 8 Suppl 1, 55–61 (2007).Google Scholar
  10. 10.
    Wang, C.Y., et al. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Science signaling 2, ra11 (2009).PubMedCrossRefGoogle Scholar
  11. 11.
    Sato, A., et al. Anti-obesity Effect of Eicosapen-taenoic Acid in High-fat/High-sucrose Diet-induced Obesity: Importance of Hepatic Lipogenesis. Diabetes (2010).Google Scholar
  12. 12.
    Inui, A. Obesity – a chronic health problem in cloned mice? Trends Pharmacol Sci 24, 77–80 (2003).PubMedCrossRefGoogle Scholar
  13. 13.
    Cox, L.S. & Mattison, J.A. Increasing longevity through caloric restriction or rapamycin feeding in mammals: common mechanisms for common outcomes? Aging Cell 8, 607–613 (2009).PubMedCrossRefGoogle Scholar
  14. 14.
    Chang, G.R., et al. Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice. J Pharmacol Sci 109, 496–503 (2009).PubMedCrossRefGoogle Scholar
  15. 15.
    Um, S.H., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200–205 (2004).PubMedCrossRefGoogle Scholar
  16. 16.
    Friedman, J.M., Leibel, R.L., Bahary, N., Siegel, D.A. & Truett, G. Genetic analysis of complex disorders. Molecular mapping of obesity genes in mice and humans. Ann N Y Acad Sci 630, 100–115 (1991).Google Scholar
  17. 17.
    Begin-Heick, N. Of mice and women: the beta 3-adrenergic receptor leptin and obesity. Biochem Cell Biol 74, 615–622 (1996).PubMedCrossRefGoogle Scholar
  18. 18.
    Coleman, D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141–148 (1978).PubMedCrossRefGoogle Scholar
  19. 19.
    Walley, A.J., Asher, J.E. & Froguel, P. The genetic contribution to non-syndromic human obesity. Nat Rev Genet 10, 431–442 (2009).PubMedCrossRefGoogle Scholar
  20. 20.
    Turek, F.W., et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308, 1043–1045 (2005).PubMedCrossRefGoogle Scholar
  21. 21.
    Sjogren, K., et al. Body fat content can be predicted in vivo in mice using a modified dual-energy X-ray absorptiometry technique. J Nutr 131, 2963–2966 (2001).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC  2012

Authors and Affiliations

  1. 1.Second Section of Cardiology, Department of MedicineChang Gung Memorial Hospital and Chang Gung University College of MedicineTaoyuanTaiwan
  2. 2.Vascular Medicine Research UnitBrigham and Women’s Hospital and Harvard Medical SchoolCambridgeUSA

Personalised recommendations